129 related articles for article (PubMed ID: 16556889)
1. Developmental regulation of the adhesive and enzymatic activity of vascular adhesion protein-1 (VAP-1) in humans.
Salmi M; Jalkanen S
Blood; 2006 Sep; 108(5):1555-61. PubMed ID: 16556889
[TBL] [Abstract][Full Text] [Related]
2. The oxidase activity of vascular adhesion protein-1 (VAP-1) induces endothelial E- and P-selectins and leukocyte binding.
Jalkanen S; Karikoski M; Mercier N; Koskinen K; Henttinen T; Elima K; Salmivirta K; Salmi M
Blood; 2007 Sep; 110(6):1864-70. PubMed ID: 17548577
[TBL] [Abstract][Full Text] [Related]
3. Human vascular adhesion protein-1 (VAP-1) plays a critical role in lymphocyte-endothelial cell adhesion cascade under shear.
Salmi M; Tohka S; Jalkanen S
Circ Res; 2000 Jun; 86(12):1245-51. PubMed ID: 10864915
[TBL] [Abstract][Full Text] [Related]
4. Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells.
Lalor PF; Edwards S; McNab G; Salmi M; Jalkanen S; Adams DH
J Immunol; 2002 Jul; 169(2):983-92. PubMed ID: 12097405
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1).
Koskinen K; Vainio PJ; Smith DJ; Pihlavisto M; Ylä-Herttuala S; Jalkanen S; Salmi M
Blood; 2004 May; 103(9):3388-95. PubMed ID: 14726375
[TBL] [Abstract][Full Text] [Related]
6. Different forms of human vascular adhesion protein-1 (VAP-1) in blood vessels in vivo and in cultured endothelial cells: implications for lymphocyte-endothelial cell adhesion models.
Salmi M; Jalkanen S
Eur J Immunol; 1995 Oct; 25(10):2803-12. PubMed ID: 7589075
[TBL] [Abstract][Full Text] [Related]
7. Cloning and characterization of mouse vascular adhesion protein-1 reveals a novel molecule with enzymatic activity.
Bono P; Salmi M; Smith DJ; Jalkanen S
J Immunol; 1998 Jun; 160(11):5563-71. PubMed ID: 9605161
[TBL] [Abstract][Full Text] [Related]
8. A peptide inhibitor of vascular adhesion protein-1 (VAP-1) blocks leukocyte-endothelium interactions under shear stress.
Yegutkin GG; Salminen T; Koskinen K; Kurtis C; McPherson MJ; Jalkanen S; Salmi M
Eur J Immunol; 2004 Aug; 34(8):2276-85. PubMed ID: 15259025
[TBL] [Abstract][Full Text] [Related]
9. Human vascular adhesion protein 1 (VAP-1) is a unique sialoglycoprotein that mediates carbohydrate-dependent binding of lymphocytes to endothelial cells.
Salmi M; Jalkanen S
J Exp Med; 1996 Feb; 183(2):569-79. PubMed ID: 8627168
[TBL] [Abstract][Full Text] [Related]
10. Functional modulation of vascular adhesion protein-1 by a novel splice variant.
Kaitaniemi S; Grön K; Elovaara H; Salmi M; Jalkanen S; Elima K
PLoS One; 2013; 8(1):e54151. PubMed ID: 23349812
[TBL] [Abstract][Full Text] [Related]
11. Induction and function of vascular adhesion protein-1 at sites of inflammation.
Salmi M; Kalimo K; Jalkanen S
J Exp Med; 1993 Dec; 178(6):2255-60. PubMed ID: 8245796
[TBL] [Abstract][Full Text] [Related]
12. Vascular adhesion protein-1 (VAP-1) mediates lymphocyte-endothelial interactions in chronic kidney rejection.
Kurkijärvi R; Jalkanen S; Isoniemi H; Salmi M
Eur J Immunol; 2001 Oct; 31(10):2876-84. PubMed ID: 11592062
[TBL] [Abstract][Full Text] [Related]
13. Vascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetes.
Noda K; Nakao S; Zandi S; Engelstädter V; Mashima Y; Hafezi-Moghadam A
Exp Eye Res; 2009 Nov; 89(5):774-81. PubMed ID: 19635478
[TBL] [Abstract][Full Text] [Related]
14. Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseases.
Solé M; Unzeta M
Biol Cell; 2011 Nov; 103(11):543-57. PubMed ID: 21819380
[TBL] [Abstract][Full Text] [Related]
15. Vascular adhesion protein 1 (VAP-1) mediates lymphocyte subtype-specific, selectin-independent recognition of vascular endothelium in human lymph nodes.
Salmi M; Tohka S; Berg EL; Butcher EC; Jalkanen S
J Exp Med; 1997 Aug; 186(4):589-600. PubMed ID: 9254657
[TBL] [Abstract][Full Text] [Related]
16. VAP-1: an adhesin and an enzyme.
Salmi M; Jalkanen S
Trends Immunol; 2001 Apr; 22(4):211-6. PubMed ID: 11274927
[TBL] [Abstract][Full Text] [Related]
17. Carbohydrates located on the top of the "cap" contribute to the adhesive and enzymatic functions of vascular adhesion protein-1.
Maula SM; Salminen T; Kaitaniemi S; Nymalm Y; Smith DJ; Jalkanen S
Eur J Immunol; 2005 Sep; 35(9):2718-27. PubMed ID: 16082728
[TBL] [Abstract][Full Text] [Related]
18. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases.
Kurkijärvi R; Adams DH; Leino R; Möttönen T; Jalkanen S; Salmi M
J Immunol; 1998 Aug; 161(3):1549-57. PubMed ID: 9686623
[TBL] [Abstract][Full Text] [Related]
19. Human vascular adhesion protein-1 in smooth muscle cells.
Jaakkola K; Kaunismäki K; Tohka S; Yegutkin G; Vänttinen E; Havia T; Pelliniemi LJ; Virolainen M; Jalkanen S; Salmi M
Am J Pathol; 1999 Dec; 155(6):1953-65. PubMed ID: 10595925
[TBL] [Abstract][Full Text] [Related]
20. Origins of serum semicarbazide-sensitive amine oxidase.
Stolen CM; Yegutkin GG; Kurkijärvi R; Bono P; Alitalo K; Jalkanen S
Circ Res; 2004 Jul; 95(1):50-7. PubMed ID: 15178639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]